Jane Street’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-426
Closed -$11.2K – 12151
2026
Q1
$11.2K Buy
426
+235
+123% +$29.5K ﹤0.01% 11294
2025
Q4
$47.4K Sell
191
-64
-25% -$14.6K ﹤0.01% 10522
2025
Q3
$53.7K Buy
+255
New +$45K ﹤0.01% 10333
2023
Q4
– Sell
-499
Closed -$33.2K – 9409
2023
Q3
$33.2K Buy
+499
New +$46K ﹤0.01% 8230
2023
Q1
– Sell
-226
Closed -$39.3K – 9352
2022
Q4
$39.3K Buy
+226
New +$149K ﹤0.01% 8439
2020
Q4
– Sell
-221
Closed -$220K – 7713
2020
Q3
$220K Buy
+221
New +$234K ﹤0.01% 6310

Other funds holding GOSS

Jane Street's GOSS Position: Q3 2026 in Review

Jane Street opened a new position in Gossamer Bio (GOSS) in Q3 2026: 37,652 shares worth $446K. The stake represents ﹤0.01% of the portfolio and ranks #8282 among its holdings. This is a return to the name: Jane Street previously reported a position in GOSS as recently as Q4 2025.

Jane Street first reported a position in GOSS in Q3 2020 and has held it in 20 quarters since. The position peaked at $1.85M in Q3 2025. 37 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Jane Street held 37,652 shares of Gossamer Bio worth $446K as of Q3 2026.
  • Gossamer Bio was a new Jane Street position in Q3 2026.
  • Gossamer Bio made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #8282 holding.
  • Jane Street first reported a position in Gossamer Bio in Q3 2020 and has held it in 20 quarters since.
  • Jane Street's Gossamer Bio position peaked at $1.85M in Q3 2025.
  • 37 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.